Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates
HRTXHeron Therapeutics(HRTX) ZACKS·2024-08-07 07:46

Heron Therapeutics (HRTX) came out with a quarterly loss of 0.06pershareversustheZacksConsensusEstimateofalossof0.06 per share versus the Zacks Consensus Estimate of a loss of 0.04. This compares to loss of 0.35pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−500.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -50%. A quarter ago, it was expected that this pharmaceutical company would post a loss of 0.08 per share when it actually produced a loss of $0.02, delivering a surprise of 75%.Over the last four quarters, the company ...